Search results

The Promobilia Foundation is investing SEK 25 million in a new large-scale research project targeting Parkinson’s disease. The donation enables four research groups—one at Lund University and three at Karolinska Institutet—to join forces in developing new treatment strategies that address the root causes of the disease. Using innovative approaches, including advanced gene therapies and targeted ve

https://www.multipark.lu.se/article/promobilia-foundation-invests-sek-25-million-new-large-scale-research-project-targeting-parkinsons - 2026-05-01

Almost half of all dementia cases may be associated with modifiable factors such as smoking and high blood pressure. At the same time, some risk factors are built into our biology, such as age, sex, and genetics. But dementia is not a single disease, rather symptom of multiple underlying disorders. Therefore, risk factor profiles for various dementia subtypes are likely to vary. A new study highli

https://www.multipark.lu.se/article/how-lifestyle-and-biology-shape-brain-changes-linked-dementia - 2026-05-01

Turning scientific knowledge into solutions that improve people’s lives is the ultimate goal of research. But the path from novel scientific data to an innovation that may impact health care is long; many promising ideas never get a fair chance. For 16 years, MultiPark Innovation has supported researchers in their first efforts in transforming discoveries into inventions that may benefit patients

https://www.multipark.lu.se/article/multipark-innovation-grants-have-generated-inventions-2011 - 2026-05-01

Modern technology is helping our researchers to get a sneak peek into the brain – and now the winning image has been chosen in MultiPark’s photo competition #Neurovision. All entries will be on display for the public at MultiPark Café’s exhibition – come and explore the secrets of the brain with us on 3 March! MultiPark is a strategic research area at Lund University, where interdisciplinary resea

https://www.multipark.lu.se/article/multiparks-vernissage-neurovision-celebrating-winners-our-photo-competitions - 2026-05-01

New blood tests for diagnosing Alzheimer’s disease are making early diagnosis increasingly feasible. However, the fact that the markers being measured change long before any symptoms develop represents a challenge. Research led by Lund University in Sweden shows that a previously unused blood marker, when combined with those markers already in use, can significantly reduce the risk of misleading d

https://www.multipark.lu.se/article/new-blood-marker-reduces-risk-false-diagnosis-alzheimers-disease - 2026-05-01

The symptom profiles of different neurodegenerative diseases often overlap, and diagnosing age-related cognitive symptoms is complex. A patient may have multiple overlapping disease processes in the brain at the same time. Now, researchers at Lund University have developed an AI model showing that it is possible to detect several neurodegenerative diseases from a single blood sample. The study is

https://www.multipark.lu.se/article/new-ai-model-can-detect-multiple-cognitive-brain-diseases-single-blood-sample - 2026-05-01

Simpler diagnosis using a smell test, mapping brain circuits behind symptoms linked to Parkinson’s, and significant funding for advanced gene therapies. And a recently completed clinical trial with promising results for stem cell-based transplantation in Parkinson’s patients. These are five examples from the strategic research area MultiPark over the past year. MultiPark conducts multidisciplinary

https://www.multipark.lu.se/article/world-parkinsons-day-five-multipark-projects-could-improve-diagnosis-understanding-and-future - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. How do you stop Alzheimer’s disease without a simple way to diagnose it? It’s a real chicken and egg problem, as I wrote last year on TGN. Discovering a treatment for Alzheimer’s requires lots of clinical trials for new drugs—but it’s difficult to enroll participants without a way to identify people who have the disea

https://www.multipark.lu.se/article/unexpected-way-we-might-one-day-diagnose-alzheimers - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. A new study confirms that a simple blood test can reveal whether there is accelerating nerve cell damage in the brain. The researchers analysed neurofilament light protein (NFL) in blood samples from patients with Alzheimer’s disease. Recently published in JAMA Neurology, the study suggests that the NFL concentration

https://www.multipark.lu.se/article/more-evidence-blood-tests-can-detect-risk-alzheimers - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. In recent years, it has become increasingly clear to researchers that the protein galectin-3 is involved in inflammatory diseases in the brain. A study led by researchers at Lund University in Sweden now shows the de facto key role played by the protein in Alzheimer’s disease. When the researchers shut off the gene th

https://www.multipark.lu.se/article/researchers-block-protein-plays-key-role-alzheimers-disease - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. Daniella was awarded the prize for "successful effort as a young researcher and group leader". Link to Jeanssons Foundation website (in Swedish)

https://www.multipark.lu.se/article/daniella-ottosson-receives-prize-jeanssons-foundation - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. The Future Faculty is proud to present the 2019 Minerva Award to Tomas Deierborg, associate professor at the Department of Experimental Medical Sciences.The Minerva award selection committee's motivation for the choice is: "The core values of the Minerva award are honesty, trust, fairness, respect, responsibility and

https://www.multipark.lu.se/article/minerva-award-tomas-deierborg - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. In today’s JAMA Neurology, researchers led by Oskar Hansson, Lund University, Sweden, report how a fully automated immunoassay for plasma Aβ performed when they put it through its paces. Roche Diagnostic’s Elecsys system predicted Aβ-positive individuals with about 80 percent accuracy. That number improved by 5 percen

https://www.multipark.lu.se/article/drawing-closer-alzheimers-blood-test-primary-care - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. Scientists are becoming more nuanced in how they use amyloid scans—not just to detect the presence of Alzheimer’s pathology, but also to pinpoint disease stage. At this year’s Alzheimer’s Association International Conference, held July 13–18 in Los Angeles, researchers led by Niklas Mattsson and Oskar Hansson at Lund

https://www.multipark.lu.se/article/new-pet-staging-scheme-amyloid - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. On October 30, MultiPark arranged, in collaboration with the Parkinson Skåne patient organization and Studieförbundet Vuxenskolan, a half-day study visit for the public to the Biomedical Center. Professor Angela Cenci Nilsson led the event and guided the audience through the afternoon.       The chair of Parkinson Skå

https://www.multipark.lu.se/article/parkinson-skane-visits-bmc - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. Oskar Hansson, professor of neurology at Lund University and cheif physician at Skåne University Hospital, is included in this year´s list of highly cited researchers that Web of Science compiles each year.Read the article (in Swedish) on the Faculty of Medicine website.

https://www.multipark.lu.se/article/congratulations-oskar-hansson-list-highly-cited-2019 - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. Half as many diagnosed with depression, a delayed manifestation of Parkinson’s, a reduced risk of developing vascular dementia - but not Alzheimer’s. These connections were discovered by researchers when they compared 200 000 people who had participated in a long-distance cross-country ski race between 1989 and 2010 w

https://www.multipark.lu.se/article/skiers-had-lower-incidence-depression-and-vascular-dementia-not-alzheimers - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. Neuroscientists at Lund University in Sweden have developed a new technology that engineers the shell of a virus to deliver gene therapy to the exact cell type in the body that needs to be treated. The researchers believe that the new technology can be likened to dramatically accelerating evolution from millions of ye

https://www.multipark.lu.se/article/high-tech-method-uniquely-targeted-gene-therapy-developed - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. Dr Rana Soylu Kucharz presented her recent project with the title "Striatal Neuropathology induced by Hypothalamic Overexpression of Huntingtin Fragments using Adeno-associated Viral Vectors in Mice” as an oral presentation in the Short Communication session at the EHDN meeting in the Hague, the Netherlands, in Septem

https://www.huntington-research.lu.se/article/tnus-research-selected-oral-presentation-ehdn-meeting - 2026-05-01

This article is over 5 years old, and the information may therefore be outdated. Welcome to Jo Henningsen who started her postdoctoral fellowship two weeks ago with TNU. Jo will work on hypothalamic dysfunction in HD, and will be engaged in collaborations with the BRAINS unit.

https://www.huntington-research.lu.se/article/welcome-our-new-postdoc-jo-henningsen - 2026-05-01